We are advised by Bridge to Life, Ltd. that journalists and other readers should disregard the news release, Bridge to Life(TM) Secures FDA De Novo Clearance for VitaSmart(TM) Hypothermic Oxygenated Perfusion (HOPE) System, the First Device Cleared in the U.S. for Hypothermic Oxygenated Perfusion of Donor Livers, issued 20-Jan-2026 over PR Newswire.
SOURCE Bridge to Life, Ltd.
https://rt.newswire.ca/rt.gif?NewsItemId=CG65361&Transmission_Id=202601200711PR_NEWS_USPR_____CG65361A&DateId=20260120
COMTEX_472169312/1005/2026-01-20T07:11:54